Cancel
About Bryan Smith
Bryan Smith is the General Counsel, Corporate Secretary, and Chief Compliance Officer of Eledon since April 2021, with a background in leadership roles at Urovant Sciences and Allergan, and experience as a litigator at Gibson, Dunn & Crutcher LLP.
Known information
Bryan Smith serves as the General Counsel, Corporate Secretary, and Chief Compliance Officer of Eledon, a role he has held since April 2021. Prior to joining Eledon, Smith held similar positions at Urovant Sciences. He also has extensive experience at Allergan, where he most recently served as Associate Vice President and chief counsel to the company’s urology, neurology, aesthetics, and dermatology business units. Earlier in his career, Smith was a litigator at the law firm Gibson, Dunn & Crutcher LLP. He holds a B.A. in Political Science from Brigham Young University and earned his J.D. from the University of Southern California Law School. Additionally, he served as a law clerk to the Honorable Cormac J. Carney in the United States District Court for the Central District of California.
About Eledon Pharmaceuticals
Eledon Pharmaceuticals develops immune-modulating therapies for life-threatening conditions, with a focus on their lead investigational product, tegoprubart. The company is headquartered in Irvine, California, and conducts clinical trials in kidney transplantation, xenotransplantation, and ALS.
Report inaccurate information
